Past Events

Large-Scale Studies to Identify Risk Genes for Cancers - Dr. Bogdan Pasaniuc

DCEG Seminar

Genomics of Helicobacter pylori and Human Papillomavirus - Dr. Camargo

DCEG Events

Human Telomeres Genetics, Evolution and the Cancer-Atherosclerosis Trade-off - Dr. Abraham Aviv

Evaluating the Intersection Between Birth Defects and Childhood Cancer: An Integrated Epidemiologic and Genomic Approach - Dr. Philip Lupo

Recent Updates in the Genomics of Burkitt Lymphoma and Other Cancers - Dr. Reiner Siebert

SEER Today and Tomorrow? - Dr. Lynne Penberthy

DCEG Events

The Mexican Teachers' Cohort - Challenges and Future Directions - Dr. Martin Lajous

DCEG Events

Getting Ahead of Cancer: Prediction and Prevention - Sir John Burn, M.D.

DCEG Events

Visiting Scholar Sir John Burn, M.D., Professor of Clinical Genetics, Institute of Medicine, Newcastle University, U.K., delivers the Visiting Scholar Seminar titled "Getting Ahead of Cancer: Prediction and Prevention".

Lung Screening Economics: From Resource Utilization to Research Utilization - Dr. Sonya Cressman

DCEG Events

Lung cancer screening has the potential to save more lives than most other cancer control interventions

Finnish Maternity Cohort: Serum Biobank and National Registries - Dr. Helja Marie Surcel

DCEG Events

The Finnish Maternity Cohort (FMC) is a biobank comprising virtually the entire population of women in Finland who have been pregnant between 1983 -2016. The FMC is linkable with population-based health registers including the Finnish Cancer Registry and the Medical Birth Register. Serial prediagnostic serum samples and comprehensive data accessible over three generations provide possibilities for unique study settings. The FMC has made substantial contributions to the scientific literature in terms of our understanding of the associations of various biomarkers with the later health of the mother and child. Studies include epidemiological research of infections associated with certain cancers (cervix, breast, leukemia) and linkage of prenatal exposures/biomarkers (smoking, alcohol, Vitamin D, persistent organic pollutants, steroid hormones, thyroid hormones and antibodies) with development of multiple sclerosis, with mental disorder of the child, or with pregnancy outcomes in general. Dr. Surcel’s presentation will focus on the principles and guidelines for how FMC biospecimens combined with health register data and archived pathologic samples are made available to researchers.